Cadence, a health technology company, has partnered with the nonprofit Catholic health system Providence to expand remote patient monitoring (RPM) and virtual care capabilities across seven US states. The aim is to allow healthcare providers to collect vital signs remotely while allowing patients to remain at home, enhancing chronic disease management. Providence’s goal is to extend its clinical team into patients’ homes to improve care quality for those with chronic conditions while streamlining the patient experience. The RPM solution and responsive virtual care program have demonstrated efficacy, and the partnership plans to scale the program to support patients throughout Providence’s seven-state footprint.
A new partnership between Cadence and Providence seeks to expand remote patient monitoring (RPM) and responsive virtual care capabilities to clinics across seven states, enabling healthcare providers to remotely collect vital signs while allowing patients to remain at home. The nonprofit Catholic health system Providence operates in Alaska, California, Montana, New Mexico, Oregon, Texas, and Washington, and includes 52 hospitals and more than 900 clinics. The partnership with Cadence, a health technology company, will add an RPM solution and a responsive virtual care program to enhance chronic disease management.
Through technology and a nurse practitioner-led clinical care team, Providence aims to extend its clinical team into patients’ homes, allowing the healthcare provider to enhance the quality of care it provides to patients with chronic conditions while streamlining the patient experience. According to David Kim, MD, the chief executive of the Providence Clinical Network, the early clinical outcomes, and provider and patient satisfaction results are promising, and they look forward to the progress and momentum ahead.
In June 2022, the two organizations implemented the RPM program at two Washington clinics, St. Mary Cardiology, and Lacey Family Medicine. The goal of the program is to support patient outcomes by incorporating lifestyle modifications and guideline-based medication management. Of the 300 patients participating in the program, 89 percent take vitals daily, and only 0.2 percent of remote encounters escalated to engagement with Providence clinicians. This has demonstrated the efficacy of the program, and additional benefits include increased adherence to guideline-directed medical therapies (GDMT) and reductions in blood pressure among hypertension patients.
The partnership aims to scale the program to support patients throughout Providence’s seven-state footprint. In 2023, the program will be extended across Washington service areas, and it currently supports hypertension, congestive heart failure, and type 2 diabetes. The health system also plans to add chronic obstructive pulmonary disease (COPD) care to the program in 2024.
According to Chris Altchek, founder and CEO of Cadence, Providence’s focus on improving health equity and access at scale is deeply aligned with Cadence’s mission. Altchek said, “Providence patients enrolled in Cadence are more engaged in their care and their clinicians are supported by a team that acts as an extension of their staff. Our teams will remain focused on delivering transformative outcomes to patients who battle chronic conditions.”
Recent studies have shown the potential of RPM solutions, indicating that their use can provide various benefits. For example, research published in the International Journal of Chronic Obstructive Pulmonary Disease in March described the benefits that COPD patients experienced following remote cardiorespiratory monitoring. The study involved a retrospective analysis of unplanned hospitalizations in a cohort of 126 COPD patients. After analyzing the electronic medical record (EMR) data of patients one year before and after the beginning of the intervention, they found that the RPM program led to a 65-percent decrease in the frequency of all-cause hospitalizations in the cohort.
